ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,564.41
1.08%
US Tech 100
19,304.80
0.00%
다우존스 지수
40,421.36
0.33%
Bitcoin
66,597.72
-1.49%
Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Healthwell Acquisition Corporation I (HWEL)

  7. Healthwell Acquisition Corporation I (HWEL) 뉴스

HWEL

Healthwell Acquisition C... (HWEL)

Healthwell Acquisition Corporation I
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:HWEL
일자시간출처헤드라인심볼기업
2023/11/1811:29Business WireHealthwell Acquisition Corp. I Announces Cancellation of Special Stockholder Meeting and its Intention to LiquidateNASDAQ:HWELHealthwell Acquisition Corporation I
2023/11/0408:00Business WireHealthwell Acquisition Corp. I Announces Termination of Business Combination with Starton Therapeutics, Inc.NASDAQ:HWELHealthwell Acquisition Corporation I
2023/10/2412:55Business WireHealthwell Acquisition Corp. I Announces Postponement of the Special Meeting of Stockholders to Approve the Proposed Business Combination with Starton Therapeutics, Inc. and Related TransactionsNASDAQ:HWELHealthwell Acquisition Corporation I
2023/10/1719:00Business WireHealthwell Acquisition Corp. I Announces New Meeting Date for the Special Meeting of Stockholders to Approve Proposed Business Combination With Starton Therapeutics, Inc. and Related TransactionsNASDAQ:HWELHealthwell Acquisition Corporation I
2023/10/0421:00Business WireStarton Therapeutics Doses First Patient in Landmark STAR-LLD Lenalidomide Phase 1b Clinical Trial in Multiple MyelomaNASDAQ:HWELHealthwell Acquisition Corporation I
2023/09/1405:05Business WireStarton Therapeutics Announces the Opening of the First Clinical Site for STAR-LLD Lenalidomide Phase 1b Trial in Multiple MyelomaNASDAQ:HWELHealthwell Acquisition Corporation I
2023/07/1020:00Business WireStarton Therapeutics Contracts Global Clinical Research Organization to Conduct STAR-LLD Phase 1b Clinical Trial in Multiple MyelomaNASDAQ:HWELHealthwell Acquisition Corporation I
2023/06/2406:20Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:HWELHealthwell Acquisition Corporation I
2023/06/1323:29Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:HWELHealthwell Acquisition Corporation I
2023/06/1323:28Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:HWELHealthwell Acquisition Corporation I
2023/06/1305:44Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:HWELHealthwell Acquisition Corporation I
2023/06/1305:43Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:HWELHealthwell Acquisition Corporation I
2023/06/1305:30Business WireStarton Therapeutics Receives Authorization from the FDA to Proceed with STAR-LLD Lenalidomide Phase 1b Clinical Trial in Multiple MyelomaNASDAQ:HWELHealthwell Acquisition Corporation I
2023/06/0723:52Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:HWELHealthwell Acquisition Corporation I
2023/06/0621:41Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:HWELHealthwell Acquisition Corporation I
2023/06/0621:40Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:HWELHealthwell Acquisition Corporation I
2023/06/0621:00Business WireStarton Therapeutics, Inc. and Healthwell Acquisition Corp. I to Present at the Jefferies Healthcare ConferenceNASDAQ:HWELHealthwell Acquisition Corporation I
2023/05/1906:10Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:HWELHealthwell Acquisition Corporation I
2023/05/1606:31Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:HWELHealthwell Acquisition Corporation I
2023/05/1606:29Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:HWELHealthwell Acquisition Corporation I
2023/05/1605:21Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:HWELHealthwell Acquisition Corporation I
2023/05/0406:04Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:HWELHealthwell Acquisition Corporation I
2023/04/2720:21Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:HWELHealthwell Acquisition Corporation I
2023/04/2720:17Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:HWELHealthwell Acquisition Corporation I
2023/04/2720:00Business WireStarton Therapeutics Inc. and Healthwell Acquisition Corp. I to Combine and Create Publicly Traded Leader in Proprietary Continuous Delivery Technology for Cancer TreatmentsNASDAQ:HWELHealthwell Acquisition Corporation I
2023/03/2406:08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:HWELHealthwell Acquisition Corporation I
2023/02/1507:42Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:HWELHealthwell Acquisition Corporation I
2023/02/1420:08Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:HWELHealthwell Acquisition Corporation I
2023/02/1406:02Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:HWELHealthwell Acquisition Corporation I
2023/02/1107:02Edgar (US Regulatory)

NASDAQ:HWELHealthwell Acquisition Corporation I
 검색 관련기사 보기:NASDAQ:HWEL

최근 히스토리

LSE
FEUR
Fid Sre Eu Etf
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유